In addition, the two proinflammatory pathways, NLRP3 inflammasome and NF-κB/TNF-⍺ signaling cascade were significantly inhibited by sotagliflozin treatment in the post-MI heart. This evidence concerns the gene NLRP3 and myocardial infarction.